These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37565977)

  • 21. Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
    Belyavskiy E; Morris DA; Url-Michitsch M; Verheyen N; Meinitzer A; Radhakrishnan AK; Kropf M; Frydas A; Ovchinnikov AG; Schmidt A; Tadic M; Genger M; Lindhorst R; Bobenko A; Tschöpe C; Edelmann F; Pieske-Kraigher E; Pieske B
    ESC Heart Fail; 2019 Feb; 6(1):146-153. PubMed ID: 30451399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial.
    Patel KV; Mauricio R; Grodin JL; Ayers C; Fonarow GC; Berry JD; Pandey A
    ESC Heart Fail; 2019 Aug; 6(4):613-620. PubMed ID: 30993916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction.
    Spiesshoefer J; Henke C; Kabitz HJ; Bengel P; Schütt K; Nofer JR; Spieker M; Orwat S; Diller GP; Strecker JK; Giannoni A; Dreher M; Randerath WJ; Boentert M; Tuleta I
    Respiration; 2021; 100(2):96-108. PubMed ID: 33171473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, Demographic, and Imaging Correlates of Anemia in Heart Failure With Preserved Ejection Fraction (from the RELAX Trial).
    Parcha V; Patel N; Kalra R; Bhargava A; Prabhu SD; Arora G; Arora P
    Am J Cardiol; 2020 Jun; 125(12):1870-1878. PubMed ID: 32307089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction.
    Hearon CM; Sarma S; Dias KA; Hieda M; Levine BD
    Heart; 2019 Oct; 105(20):1552-1558. PubMed ID: 31208971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    Reddy YNV; Andersen MJ; Obokata M; Koepp KE; Kane GC; Melenovsky V; Olson TP; Borlaug BA
    J Am Coll Cardiol; 2017 Jul; 70(2):136-148. PubMed ID: 28683960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.
    Abudiab MM; Redfield MM; Melenovsky V; Olson TP; Kass DA; Johnson BD; Borlaug BA
    Eur J Heart Fail; 2013 Jul; 15(7):776-85. PubMed ID: 23426022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
    Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ
    Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction.
    Koepp KE; Obokata M; Reddy YNV; Olson TP; Borlaug BA
    JACC Heart Fail; 2020 Aug; 8(8):657-666. PubMed ID: 32653449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
    Kitzman DW; Brubaker P; Morgan T; Haykowsky M; Hundley G; Kraus WE; Eggebeen J; Nicklas BJ
    JAMA; 2016 Jan; 315(1):36-46. PubMed ID: 26746456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Beta-Blocker Use With Exercise Capacity in Participants With Heart Failure With Preserved Ejection Fraction: A Post Hoc Analysis of the RELAX Trial.
    Patel L; Segar MW; Keshvani N; Subramanian V; Pandey A; Chandra A
    Am J Cardiol; 2024 Apr; 216():48-53. PubMed ID: 38336082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing.
    Pugliese NR; De Biase N; Gargani L; Mazzola M; Conte L; Fabiani I; Natali A; Dini FL; Frumento P; Rosada J; Taddei S; Borlaug BA; Masi S
    Eur J Prev Cardiol; 2021 Dec; 28(15):1650-1661. PubMed ID: 33624088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.
    Dhakal BP; Malhotra R; Murphy RM; Pappagianopoulos PP; Baggish AL; Weiner RB; Houstis NE; Eisman AS; Hough SS; Lewis GD
    Circ Heart Fail; 2015 Mar; 8(2):286-94. PubMed ID: 25344549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.
    Lyle MA; Iyer SR; Redfield MM; Reddy YNV; Felker GM; Cappola TP; Hernandez AF; Scott CG; Burnett JC; Pereira NL
    JACC Heart Fail; 2020 Jan; 8(1):70-80. PubMed ID: 31392960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of complication of type 2 diabetes mellitus with hemodynamics and exercise capacity in patients with heart failure with preserved ejection fraction: a case-control study in individuals aged 65-80 years.
    Sugita Y; Ito K; Yoshioka Y; Sakai S
    Cardiovasc Diabetol; 2023 Apr; 22(1):97. PubMed ID: 37118820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction.
    Nan Tie E; Wolsk E; Nanayakkara S; Vizi D; Mariani J; Moller JE; Hassager C; Gustafsson F; Kaye DM
    ESC Heart Fail; 2024 Oct; 11(5):2557-2565. PubMed ID: 38698563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
    Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
    JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.